BSE filing, BSE: 543461. Summary written from the filing by ALFA Finder's alert engine.
Safa Systems & Technologies Ltd: key numbers
- Share price
- ₹19.25
- Market cap
- ₹48.08 Cr
- Revenue (annual)
- ₹433.1 Cr
- Net profit (annual)
- ₹4.75 Cr
- P/E (TTM)
- 10.1×Sector 46.8×
- Promoter holding
- 49.21%
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Safa Systems & Technologies Ltd
All →Safa Systems & Technologies Other Announcement
Safa Systems & Technologies Ltd has submitted its quarterly shareholding pattern as per SEBI regulations. This is a routine regulatory compliance disclosure.
Safa Systems & Technologies Capital Structure Change
Safa Systems & Technologies issued 2.39 Crore worth of shares to promoter and promoter group entities via allotment. This increases the total paid-up share capital.
- Value
- ₹2.39 Cr
Safa Systems & Technologies Other Announcement
Safa Systems & Technologies Limited filed the quarterly compliance certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, for the quarter ended September 30, 2026.
Safa Systems & Technologies Capital Structure Change
Safa Systems & Technologies Limited allotted 23,90,000 equity shares on a preferential basis to its promoters. The issue, priced at ₹20.47 per share, raised ₹4.89 Crore.
- Value
- ₹4.89 Cr
- Promoter stake change
- +4.86%
Safa Systems & Technologies Capital Structure Change
Safa Systems & Technologies Limited received in-principle approval from BSE for a preferential issue. The company will issue 23,90,000 equity shares to promoters for ₹4.89 Crore.
- Value
- ₹4.89 Cr
Safa Systems & Technologies Management Change
Safa Systems & Technologies appointed Mr. Anupabraham Joseph as Non-Executive Independent Director for 60 months. The board approved the appointment effective 15 September 2026.
Other board meeting date announcements
All →B.D. Industries (Pune) Board Meeting Date
B. D. Industries (Pune) will hold a board meeting on 14 November 2026 to consider unaudited standalone and consolidated half-year results. The agenda items are proposed only and no decision has been taken yet.
Health X Platform Board Meeting Date
Health X Platform will hold a board meeting on 14 November 2026 to approve quarterly results. Trading window stays closed until 48 hours after declaration.
Exato Technologies Board Meeting Date
Board meeting set for November 14, 2026 to approve half-year results and an ESOP scheme. Trading window closed from October 1.
Astal Laboratories Board Meeting Date
Astal Laboratories will hold a board meeting on 13 November 2026 to consider unaudited standalone and consolidated results for the quarter and half year ended September 2026. The trading window stays closed until 48 hours after the meeting.
Brainbees Solutions Board Meeting Date
Brainbees Solutions will hold a board meeting on November 14, 2026 to approve September 2026 quarter and half-year results. Trading window stays closed until November 16.
Senco Gold Board Meeting Date
Senco Gold schedules a board meeting on 13 November 2026 to consider unaudited quarterly and half-year results. The trading window stays closed until 48 hours after declaration.